"A Vaccine for the World": U.S. Scientists Develop Low-Cost Shot to Inoculate Global South

As COVID cases skyrocket, we speak to Dr. Peter Hotez at Texas Children's Hospital about the Omicron surge, as well as his groundbreaking work developing an affordable patent-free coronavirus vaccine. Last week the Indian government gave emergency approval to the new low-cost, patent-free vaccine called Corbevax, which Hotez co-created. He says it could reach billions of people across the globe who have lacked access to the more expensive mRNA vaccines produced by Pfizer and Moderna. We can really make a vaccine for the world," says Hotez. Hotez also addresses problems stemming from ongoing vaccine hesitancy.